>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: CEVA +9.3%, CEMP +2.8%, DO +2.8%, CCRC +2.5%, SYY +0.5%

M&A news: OPWR +30% (to be acquired by Oracle (ORCL) for $10.30/share in cash ), APOL +12.8% (receives revised offer of $10.00 per share from consortium; represents best and final offer), GNC +6.7% (commences strategic and financial review to increase shareholder value), WY +1.7% (International Paper to acquire Weyerhaeuser's (WY) Pulp Business for $2.2 bln CTCM+1.5% (announces final terms of cash-out merger)

Select metals/mining stocks trading higher: AUY +4.8%, IAG +4.4%, EGO +2.9%, AG +2.7%, GDX +2.6%, ABX +2.4%,CDE +2.2%, GG +2.1%, FCX +1.9%, NEM +1.8%

Other news: ACAD +70.9% (receives FDA approval for its Nuplazid), PTX +65.3% (Point72 Asset Management discloses 5.8% passive stake), GNW +6.4% (terminates $300 mln revolving credit facility), XXII +4.9% (enters supply arrangement w/ Celanese (CE)), PBMD +4.6% (received patent for use of LAG-3 in Japan), CLF +3.4% (enters into Stipulation and Agreement of Settlement), WYNN +3.3% (Macau Gaming Inspection and Coordination Bureau reported April gross gaming revenue), JCP +2.9% (Barron's profiles positive view on JC Penney), AMID +2% (enters into securities purchase agreement with Magnolia Infrastructure Holdings), REXX +2% (Oasis discloses 4.6% passive stake), GILD +0.8% (Bloomberg details that a judge has reopened Merck (MRK) case versus Gilead (GILD) where Merck was awarded $200 mln)

Analyst comments: LLL +2.9% (upgraded to Buy from Neutral at Goldman), VALE +2.8% (upgraded to Buy from Hold at BB&T Capital Mkts), COST +0.8% (added to Focus List at JP Morgan)